Decreased Symptoms Without Augmented Skin Blood Flow in Subjects with RLS/WED After Vibration Treatment

Overview

Journal J Clin Sleep Med

Specialties Neurology
Psychiatry

Date 2016 Apr 13

PMID 27070250

Citations 4

Authors

Ulrike H Mitchell

Sterling C Hilton

Erik Hunsaker

Jan Ulfberg

Affiliations

Soon will be listed here.

Abstract

Study Objectives: Vascular disturbances leading to tissue hypoxia have been named as a possible cause for RLS/WED. Vibration to the whole body (WBV) in subjects with RLS/WED results in increased skin blood flow (SBF). The aims of this investigation were to (1) determine if a two-week treatment with WBV will decrease symptoms associated with RLS/WED and, (2) if so, determine if the mechanism for improvement in symptoms is related to an increase in SBF, as measured in flux.

Methods: Eleven subjects with RLS/WED underwent 2 weeks of 14-minute intermittent WBV and a 2-week sham treatment in randomized order. Pre and post intervention RLS symptom severity were compared. Baseline SBF was compared between subjects with RLS/WED and an age- and sex-matched control group. A crossover design (aim 1) and a matched case-control design and repeated measures design (aim 2) were used. The data analyses consisted of 2-sample and paired t-tests; where applicable we used a standard crossover design adjustment.

Results: WBV did significantly decrease symptoms associated with RLS/WED compared to baseline data and compared to sham treatment. The baseline flux was significantly lower in RLS/WED subjects than matched controls, but this deficit was negated with WBV. There was no increase in resting SBF over the 2 weeks of treatment.

Conclusions: Subjects with RLS/WED have decreased SBF but are able to increase flux to the same level as normal subjects with WBV. A 2-week intervention with WBV decreases symptoms associated with RLS/WED, but this does not seem to be related to an increase in resting SBF.

Citing Articles

Efficacy of Aerobic and Stretching Exercises in Managing Willis-Ekbom Disease (Restless Leg Syndrome) Among Hemodialysis Patients.

Altayb Ismail M, Daffalla I, Singh T, Siddique Q, Almadhoun M, Irfan R Cureus. 2024; 16(10):e71470.

PMID: 39544546 PMC: 11563054. DOI: 10.7759/cureus.71470.

Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Winkelman J, Berkowski J, DelRosso L, Koo B, Scharf M, Sharon D J Clin Sleep Med. 2024; 21(1):153-199.

PMID: 39324664 PMC: 11701280. DOI: 10.5664/jcsm.11392.

Impaired endothelial function may predict treatment response in restless legs syndrome.

Kim M, Park D, Yoon J J Neural Transm (Vienna). 2019; 126(8):1051-1059.

PMID: 31218470 DOI: 10.1007/s00702-019-02031-x.

Restless Legs Syndrome and Other Movement Disorders of Sleep-Treatment Update.

Salminen A, Winkelmann J Curr Treat Options Neurol. 2018; 20(12):55.

PMID: 30411165 DOI: 10.1007/s11940-018-0540-3.

References

Taddei S, Pedrinelli R, Salvetti A . Sympathetic nervous system-dependent vasoconstriction in humans. Evidence for mechanistic role of endogenous purine compounds. Circulation. 1990; 82(6):2061-7. DOI: 10.1161/01.cir.82.6.2061. View

Zegarra-Parodi R, Park P, Heath D, Makin I, Degenhardt B, Roustit M . Assessment of skin blood flow following spinal manual therapy: a systematic review. Man Ther. 2014; 20(2):228-49. DOI: 10.1016/j.math.2014.08.011. View

Salminen A, Rimpila V, Polo O . Peripheral hypoxia in restless legs syndrome (Willis-Ekbom disease). Neurology. 2014; 82(21):1856-61. DOI: 10.1212/WNL.0000000000000454. View

Phillips B, Young T, Finn L, Asher K, Hening W, PURVIS C . Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000; 160(14):2137-41. DOI: 10.1001/archinte.160.14.2137. View

Mitchell U, Wayne Johnson A, Myrer B . Comparison of two infrared devices in their effectiveness in reducing symptoms associated with RLS. Physiother Theory Pract. 2010; 27(5):352-9. DOI: 10.3109/09593985.2010.502210. View

Johnson P, Feland J, Wayne Johnson A, Mack G, Mitchell U . Effect of whole body vibration on skin blood flow and nitric oxide production. J Diabetes Sci Technol. 2014; 8(4):889-94. PMC: 4764225. DOI: 10.1177/1932296814536289. View

Barriere G, Cazalets J, Bioulac B, Tison F, Ghorayeb I . The restless legs syndrome. Prog Neurobiol. 2005; 77(3):139-65. DOI: 10.1016/j.pneurobio.2005.10.007. View

Wahlin-Larsson B, Ulfberg J, Piehl Aulin K, Kadi F . The expression of vascular endothelial growth factor in skeletal muscle of patients with sleep disorders. Muscle Nerve. 2009; 40(4):556-61. DOI: 10.1002/mus.21357. View

Eliasson A, Lettieri C . Sequential compression devices for treatment of restless legs syndrome. Medicine (Baltimore). 2007; 86(6):317-323. DOI: 10.1097/MD.0b013e31815b1319. View

10.

Lohman 3rd E, Petrofsky J, Maloney-Hinds C, Betts-Schwab H, Thorpe D . The effect of whole body vibration on lower extremity skin blood flow in normal subjects. Med Sci Monit. 2007; 13(2):CR71-6. View

11.

Mitchell U, Myrer J, Wayne Johnson A, Hilton S . Restless legs syndrome and near-infrared light: An alternative treatment option. Physiother Theory Pract. 2010; 27(5):345-51. DOI: 10.3109/09593985.2010.511440. View

12.

Mitchell U . Medical devices for restless legs syndrome - clinical utility of the Relaxis pad. Ther Clin Risk Manag. 2015; 11:1789-94. PMC: 4671777. DOI: 10.2147/TCRM.S87208. View

13.

Allen R, Oertel W, Walters A, Benes H, Schollmayer E, Grieger F . Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire. Sleep Med. 2013; 14(12):1375-80. DOI: 10.1016/j.sleep.2013.09.008. View

14.

Wahlin Larsson B, Kadi F, Ulfberg J, Piehl Aulin K . Skeletal muscle morphology in patients with restless legs syndrome. Eur Neurol. 2007; 58(3):133-7. DOI: 10.1159/000104712. View

15.

Ignarro L, Buga G, Wood K, Byrns R, Chaudhuri G . Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987; 84(24):9265-9. PMC: 299734. DOI: 10.1073/pnas.84.24.9265. View

16.

Mitchell U . Use of near-infrared light to reduce symptoms associated with restless legs syndrome in a woman: a case report. J Med Case Rep. 2010; 4:286. PMC: 2936319. DOI: 10.1186/1752-1947-4-286. View

17.

Ondo W . Epidemiology of restless legs syndrome. Sleep Med. 2003; 3 Suppl:S13-5. DOI: 10.1016/s1389-9457(02)00142-9. View

18.

Allen R . Minimal clinically significant change for the International Restless Legs Syndrome Study Group rating scale in clinical trials is a score of 3. Sleep Med. 2013; 14(11):1229. DOI: 10.1016/j.sleep.2013.08.001. View

19.

Aukerman M, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B . Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2006; 19(5):487-93. DOI: 10.3122/jabfm.19.5.487. View

20.

Bildt C, Alfredsson L, Punnett L, Theobald H, Torgen M, Wikman A . Effects of drop out in a longitudinal study of musculoskeletal disorders. Occup Environ Med. 2001; 58(3):194-9. PMC: 1740112. DOI: 10.1136/oem.58.3.194. View